WaveMan · Form 4
Biotechnology Value Trading Fund OS LP insider trades
> Search tickers & screens ⌘K
LIVE

Biotechnology Value Trading Fund OS LP insider trades

Biotechnology Value Trading Fund OS LP has filed 9 Form 4s with the SEC that we hold, for Kymera Therapeutics, Inc. (KYMR) (Director), Olema Pharmaceuticals, Inc. (OLMA) (Director, 10% owner), RPTX (10% owner) and Eledon Pharmaceuticals, Inc. (ELDN) (10% owner), among 5 companies in all. Across all of them we count 22 purchases worth $48.9M and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 775,278 shares of Olema Pharmaceuticals, Inc. worth $7.6M, dated 2023-09-12. The first filing on our record is dated 2022-01-26 and the latest 2026-06-25.

Kymera Therapeutics, Inc. (KYMR)

Director · 3 filings · 5 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-01-24P, purchase reported on Form 4158,041$6.0M2022-01-26
2022-01-24P, purchase reported on Form 4114,726$4.3M2022-01-26
2025-06-30P, purchase reported on Form 458,780$2.6M2025-07-01
2025-06-30P, purchase reported on Form 4115,783$5.1M2025-07-01
2025-06-30P, purchase reported on Form 4142,604$6.3M2025-07-01

Olema Pharmaceuticals, Inc. (OLMA)

Director, 10% owner · 2 filings · 5 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-06-10P, purchase reported on Form 4158,583$639.1K2022-06-14
2022-06-10P, purchase reported on Form 441,417$166.9K2022-06-14
2023-09-12P, purchase reported on Form 4775,278$7.6M2023-09-14
2023-09-12P, purchase reported on Form 452,801$519.6K2023-09-14
2023-09-12P, purchase reported on Form 4677,853$6.7M2023-09-14

RPTX

10% owner · 2 filings · 9 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-11-02P, purchase reported on Form 4492,251$1.8M2023-11-03
2023-11-02P, purchase reported on Form 472,479$260.9K2023-11-03
2023-11-02P, purchase reported on Form 4218,979$788.3K2023-11-03
2023-11-15P, purchase reported on Form 4390,507$2.0M2023-11-17
2023-11-15P, purchase reported on Form 4493,337$2.5M2023-11-17
2023-11-15P, purchase reported on Form 447,712$238.6K2023-11-17
2023-11-16P, purchase reported on Form 416,143$86.8K2023-11-17
2023-11-16P, purchase reported on Form 4125,909$677.4K2023-11-17
2023-11-16P, purchase reported on Form 4153,693$826.9K2023-11-17

Eledon Pharmaceuticals, Inc. (ELDN)

10% owner · 1 filing · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-05-05P, purchase reported on Form 4837,146-2023-05-09
2023-05-05P, purchase reported on Form 486,341-2023-05-09
2023-05-05P, purchase reported on Form 41,055,445-2023-05-09

XOMA Royalty Corp (XOMA)

Director, 10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1660683) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms